FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and drug label updates.

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

The Oregon Health Authority and public health officials said a winter, fall surge of COVID-19 and the flu are likely.

Flu, COVID and RSV rates are all expected to climb in the coming months, and this year Oregon is also facing elevated rates ...

The California Department of Public Health is encouraging all Californians to get vaccinated this season to protect ...

RSV is a highly infectious virus that is the most common cause of respiratory infections in children. A free vaccine could soon be available to help prevent it.

Last year was the first year the United States has vaccines available to protect the public against all three major ...

Covid-19 levels in the United States are high and rising, flu season is approaching quickly and RSV cases are already ...

All flu vaccines for the 2024-25 season will be trivalent, meaning they protect against three different strains of influenza: ...